Analyst Calls These 2 Drug Stocks a "Buy"

Both CRBP and NURO have been struggling on the charts

by Karee Venema

Published on Dec 26, 2018 at 3:14 PM

The shares of Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) are trading up 5.9% at $5.57, after H.C. Wainwright initiated coverage with a "buy" rating and $24 price target -- a more than 356% premium to Monday's close. The analyst in coverage said positive data from lenabasum trials could drive upside in the shares.

Analysts are already bullish on CRBP stock, with 100% of those covering the security calling it a "buy." Plus, the average 12-month price target sits all the way up at $23.43.

Looking at the charts, Corbus Pharmaceuticals stock has been in a channel of lower highs and lows since its early October peak at $8.57. Last week, the shares broke below short-term support at their 120-day moving average, and remain down 21.6% year-to-date. Should the security resume its longer-term downtrend, a re-evaluation from the upbeat analyst bunch could create headwinds for CRBP.

crbp stock chart on dec 26

H.C. Wainwright also chimed in on Neurometrix Inc (NASDAQ:NURO), starting coverage with a "buy" rating and $5 price target -- territory the penny stock hasn't explored since April 2017. The brokerage firm said it sees "plenty of room for the stock to appreciate," and said a new generation of its Quell technology could help grow market share.

At last check, NURO stock is 13.5% higher at $0.77, but running into resistance near its 20-day moving average. While this trendline has led the security on its most recent leg lower, the 200-day moving average has helped usher the shares to a 58% year-to-date loss.

nuro stock chart on dec 26


a schaeffer's exclusive

PLAY TRENDS LIKE A PRO!

5 tips to leverage profits in this FREE insider report!


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The IRS Loopholes Retirees Need to Know
Click to continue to advertiser's site.
Karuna Quintuples; Coty Rises on Kylie Deal
Coty bought a sizable stake in Kylie Jenner's business
Call Buyers Stay Behind Huntsman
HUN stock is in focus this morning following bullish brokerage attention
The IRS Loopholes Retirees Need to Know
Click to continue to advertiser's site.